Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatella species
© Senn et al. 2006
Received: 06 September 2005
Accepted: 20 January 2006
Published: 20 January 2006
Skip to main content
© Senn et al. 2006
Received: 06 September 2005
Accepted: 20 January 2006
Published: 20 January 2006
Abiotrophia and Granulicatella species, previously referred to as nutritionally variant streptococci (NVS), are significant causative agents of endocarditis and bacteraemia. In this study, we reviewed the clinical manifestations of infections due to A. defectiva and Granulicatella species that occurred at our institution between 1998 and 2004.
The analysis included all strains of NVS that were isolated from blood cultures or vascular graft specimens. All strains were identified by 16S rRNA sequence analysis. Patients' medical charts were reviewed for each case of infection.
Eleven strains of NVS were isolated during the 6-year period. Identification of the strains by 16S rRNA showed 2 genogroups: Abiotrophia defectiva (3) and Granulicatella adiacens (6) or "para-adiacens" (2). The three A. defectiva strains were isolated from immunocompetent patients with endovascular infections, whereas 7 of 8 Granulicatella spp. strains were isolated from immunosuppressed patients, mainly febrile neutropenic patients. We report the first case of "G. para-adiacens" bacteraemia in the setting of febrile neutropenia.
We propose that Granulicatella spp. be considered as a possible agent of bacteraemia in neutropenic patients.
Nutritionally variant streptococci (NVS), first described in 1961 by Frenkel and Hirsch , were classified on the basis of growth characteristics such as nutrient requirements (pyridoxal) and presence of satellitism. In 1989, based on DNA-DNA hybridisation, Bouvet et al. showed that NVS could be divided in two groups, Streptococcus defectivus and Streptococcus adiacens . In 1995, based on the genetic and phylogenetic analysis of the 16S rRNA sequences, the genus Abiotrophia and the two species A. defectiva and A. adiacens were proposed by Kawamura . In 1998, Roggenkamp et al. proposed the new species A. elegans , and in 1999, Lawson et al. proposed the species A. balaenopterae . Based on 16S rRNA heterogeneity and phenotypic differences, Kanamoto et al. proposed an additional species "Abiotrophia para-adiacens" . In 2000, A. adiacens, A. balaenopterae and A. elegans were reclassified in the new genus Granulicatella by Collins and Lawson .
Abiotrophia and Granulicatella species form part of the normal flora of the oral cavity [8–10], the genitourinary tract, and the intestinal tract . G. adiacens is isolated more frequently from oral specimens than other NVS [4, 9, 10]. Bacteraemia and endocarditis are the more frequently reported clinical infections due to Abiotrophia and Granulicatella species  and account for 4.3 to 6% of all "streptococcal" endocarditis . Isolated cases of keratitis , endophthalmitis , central nervous system infections [16–20], sinusitis, otitis media, prostatitis, cholangitis, arthritis [21–23] and osteomyelitis [24, 25] have also been reported. The high prevalence of beta-lactam and macrolide resistance among isolates of Abiotrophia and Granulicatella may pose a challenge to treat invasive infections [26–28].
In this study, we reviewed the clinical manifestations of infections due to A. defectiva and Granulicatella species that occurred at our institution over a 6-year period.
The analysis included all strains of NVS that were isolated from blood cultures or vascular graft specimens from patients admitted to our 800-bed University Hospital from January 1998 to December 2004. The automated blood culture system used in the microbiology laboratory during the study period was the Bactec 9240 (Becton Dickinson, Sparks, Md.) with the Plus aerobic/F and Lytic anaerobic/F vials (Becton Dickinson). The strains were identified to the species level using the Rapid ID32 STREPT system (Bio Mérieux SA, Marcy-l'Etoile, France).
The minimal inhibitory concentrations (MIC) of penicillin, ceftriaxone, meropenem, clarithromycin, erythromycin, quinupristin/dalfopristin, levofloxacin, vancomycin and teicoplanin were determined for each isolate by the E-test method (AB Biodisk, Solna, Sweden), using Brucella agar supplemented with haemin, vitamin K1, cystein and 5% sheep blood as test medium (BA). For vancomycin, an E-test was also performed on Mueller-Hinton agar with 5% sheep blood (BMH) and 1% vitox defined supplement (Oxoid, Basel, Switzerland). Antimicrobial susceptibilities were interpreted according to the guidelines established by the CLSI for Streptococcus spp. other than Streptococcus pneumoniae .
The patients' medical charts were reviewed and clinical characteristics (age, sex, clinical diagnosis, underlying conditions, predisposing factors, antibiotic treatment and outcome) were recorded for each case of infection due to NVS. Neutropenia was defined as a neutrophil count of <500 cells/mm3.
The design of this study was in accordance with the ethical standards of our hospital ethics committee. Because the study was retrospective, informed consent was not required.
During the six-year study period, ten patients had positive blood cultures for NVS and one had a positive culture of a vascular graft fragment. All but one positive blood culture were detected within the first twenty-four hours of incubation. The strains grew equally from both vials. All strains showed satellitism around streaks of Staphylococcus aureus. Seven of 11 strains were identified successfully to the species level using the Rapid ID32 STREPT system.
Based on their 16S rRNA sequences, 3 strains were identified as A. defectiva (isolates 1–3) and 8 as Granulicatella spp. (isolates 4–11). Isolates 1, 2 and 3 exhibited 99.6 to 99.7% 16S rRNA homology with A. defectiva strain ATCC 49176 and 92.1 to 92.4% 16S rRNA homology with G. adiacens strain ATCC 49175. Isolates 4 to 11 exhibited 92.2 to 92.5% 16S rRNA homology with A. defectiva strain ATCC 49176 and 99.8% 16S rRNA homology with G. adiacens strain ATCC 49175. Two strains, isolates 7 and 10, exhibited 100% 16S rRNA homology with "G. para-adiacens" strain TKT1 . The phylogenetic tree shown in Fig. 1 demonstrates the affiliation of strains 1,2 and 3 to the genus Abiotrophia. Phylogenetic analyses confirmed affiliation of strains 4, 5, 6, 8, 9 and 11 to G. adiacens and strains 7 and 10 to "G. para-adiacens" (Fig. 1). Strains 7 and 10 clustered with "G. para-adiacens" strain TKT1 with bootstraps of 94%, 84% and 80% in neighbour-joining, parsimony and minimum evolution analysis, supporting the node separating them from their closest neighbour G. adiacens.
According to CLSI interpretive criteria, the 3 A. defectiva strains were susceptible to all the antibiotics tested except 1 strain with a reduced susceptibly to penicillin (MIC 0.25 μg/ml). Two Granulicatella spp. showed resistance to penicillin (MIC 4 and 8 μg/ml, respectively), and intermediate susceptibility (MIC 2 μg/ml) or resistance (MIC 8 μg/ml) to ceftriaxone. One Granulicatella spp. was intermediately susceptible to penicillin (MIC 0.25 μg/ml) but sensitive to other beta-lactams. Two other strains were intermediately susceptible to ceftriaxone alone (MIC 2 μg/ml). All Granulicatella spp. strains showed vancomycin MICs of 1.5 to 2 μg/ml and teicoplanin MICs of <0.25 μg/ml with BA. MICs to vancomycin were lower when tested on BMH (MIC 0.5 to 1 μg/ml). All Granulicatella spp. strains were susceptible to meropenem, clarithromycin, erythromycin, quinupristin/dalfopristin, and levofloxacin.
The epidemiological and clinical characteristics of the patients are shown in Additional file 1. Two patients with A. defectiva infections had endocarditis, one of which also had sacroileitis. The third patient had polymicrobial (A. defectiva plus Escherichia coli) vascular graft infection related to an aorto-enteric fistula.
Seven of 8 patients with bacteraemia due to Granulicatella spp. were immunosuppressed. Underlying conditions included haematological malignancies (5), lung cancer (1) and advanced metastatic oesophageal cancer (1). Three patients had polymicrobial infections (G. adiacens plus Clostridium sordellii, Staphylococcus epidermidis or Lactobacillus rhamnosus). Six patients presented with febrile chemotherapy-induced neutropenia and mucositis, including one patient with possible infection of a catheter and one with possible endocarditis. One of the six patients with neutropenia died 10 days after bacteraemia from gastrointestinal bleeding in the setting of refractory thrombopenia. The other 5 neutropenic patients clinically improved clinically with intravenous antibiotic therapy. The 3 patients with primary bacteraemia due to Granulicatella spp. with intermediate susceptibility or resistance to penicillin were successfully treated (cases 7, 10 and 11).
A. defectiva and Granulicatella spp. are now considered as two distinct genera based on 16S rRNA tree topology and sequence divergence considerations . The review of these clinical cases suggests that each species is associated with a distinct clinical presentation: A. defectiva infections were seen in immunocompetent patients with endovascular infections, whereas 7 of 8 Granulicatella spp. bacteraemia occurred in immunosuppressed, mainly febrile neutropenic patients. To date, no cases of A. defectiva and only five cases of Granulicatella spp. bacteraemia in neutropenic patients have been reported. Pierard et al. described one case of G. adiacens bacteraemia among 62 cases of streptococcal bacteraemia in neutropenic patients . In a small series published by Woo et al., three cases of G. adiacens bacteraemia were associated with febrile neutropenia in cancer patients . Finally, one case of G. elegans bacteraemia was reported by Murray et al. in a febrile neutropenic cancer patient . We report here the first case of "G. para-adiacens" infection in the setting of febrile neutropenia.
One and two of 8 Granulicatella spp. strains, respectively, showed reduced susceptibility and resistance to penicillin. This rate of resistance is similar to the prevalence of penicillin resistance recently described [26, 28]. This suggests that antimicrobial susceptibility testing should be systematically done in order to select appropriate antimicrobial therapy. In severely ill patients or those with a suboptimal response to initial therapy with beta-lactam antibiotics, treatment with vancomycin should be considered. We did not observed therapeutic failures; the fatal outcome in two cases was not attributed to the infection.
All Abiotrophia and Granulicatella strains were susceptible to vancomycin. However, depending on the culture medium used for E-test method, we observed discrepant results. Overestimation of vancomycin E-test values have previously been reported for Strepococci spp., when compared to values obtained with broth or agar dilution methods [38–40]. Vancomycin E-test values should thus be interpreted with caution.
As observed in this series, Granulicatella spp. bacteraemia may occur in the setting of chemotherapy-associated mucositis and neutropenia. Oro-intestinal colonisation by Granulicatella spp. and subsequent mucositis may represent predisposing factors for bacteraemia in neutropenic patients, as it is well documented for viridans streptococci [41, 42]. The absence of cases of bacteraemia due to A. defectiva in neutropenic patients could reflect a lower frequency of oral colonisation by this species in comparison to Granulicatella spp. In one study, the rates of oral colonisation in healthy students were 11.8% and 87.1% for A. defectiva and G. adiacens, respectively .
We report six cases of bacteraemia due to Granulicatella spp. in febrile neutropenic patients. Chemotherapy-induced neutropenia and oral mucositis may represent predisposing factors. Granulicatella spp. should be considered as a possible agent of bacteraemia in neutropenic cancer patients.
We thank Dr Philip E. Tarr for critical reading of the manuscript.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.